The clinical research director of the University of California, San Fransciso’s Multiple Sclerosis Center discussed the findings of a 230-patient study of inebilizumab versus placebo in NMOSD.
Videos
The distinguished professor and director of cell biology at Missouri State University discussed the findings of a model of nVNS which suggested it operates through a novel mechanism compared to available migraine therapies.
Neurology News Network for the week ending August 31, 2019.
Neurology News Network for the week ending August 24, 2019.
The child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program
2
NeurologyLive® Friday 5 — June 5, 2026
3
Anti-PACAP Antibody Bocunebart Meets Primary Endpoint in Phase 2b Migraine Prevention Trial
4
Reflecting on World MS Day: The Growing Impact of Specialty Pharmacy Integration in MS Care
5